By contrast, 8.3% (5 cases) of adenocarcinoma cases were negative for Ber-EP4 (i.e., 2 cases of breast cancer, 1 case of endometrium cancer, 1 case of lung cancer, and 1 case of unknown origin). This evidence concerns the gene PTGER4 and breast cancer.